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ABSTRACT The purpose of this study was to deﬁne the
relationship in polymicrobial sepsis (in adultmaleC57BL/
6 mice) between heart dysfunction and the appearance
in plasma of extracellular histones. Procedures included
induction of sepsis by cecal ligation and puncture and
measurement of heart function using echocardiogram/
Doppler parameters. We assessed the ability of histones to
cause disequilibrium in the redox status and intracellular
[Ca2+]i levels in cardiomyocytes (CMs) (from mice and
rats).We also studied the ability of histones to disturb both
functional and electrical responses of hearts perfusedwith
histones.Mainﬁndings revealed that extracellular histones
appearing in septic plasma required C5a receptors, poly-
morphonuclear leukocytes (PMNs), and the Nacht-, LRR-,
and PYD-domains–containing protein 3 (NLRP3) inﬂam-
masome. In vitro exposure of CMs to histones caused loss
ofhomeostasis of the redox systemand in [Ca2+]i, aswell as
defects inmitochondrial function. Perfusionof heartswith
histones caused electrical and functional dysfunction. Fi-
nally, in vivo neutralization of histones in septic mice
markedly reduced the parameters of heart dysfunction.
Histones caused dysfunction in hearts during poly-
microbial sepsis. These events could be attenuated by
histone neutralization, suggesting that histones may be
targets in the setting of sepsis to reduce cardiac dys-
function.—Kalbitz, M., Grailer, J. J., Fattahi, F., Jajou, L.,
Herron, T. J., Campbell, K. F., Zetoune, F. S., Bosmann,
M., Sarma, J. V., Huber-Lang, M., Gebhard, F., Loaiza, R.,
Valdivia,H.H., Jalife, J.,Russell,M.W.,Ward,P.A.Roleof
extracellular histones in the cardiomyopathy of sepsis.
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MYOCARDIAL DYSFUNCTION is observed in 50% of patients di-
agnosedwith sepsis (1)and is correlatedwithmortality rates
as high as 70% (2). Defects in cardiac performance during
sepsis appear to be reversible in patients who survive sepsis
(3, 4). Products known as damage-associated molecular
patterns (DAMPs) (5) are released from cells during sepsis
or are actively secretedas endogenous alarmsignals towarn
the host of danger (6). Extracellular histones function as
endogenous DAMPs, which may interact with toll-like re-
ceptor (TLR)2 andTLR4ona variety of different cell types,
including cardiomyocytes (CMs) (7–9). Circulating extra-
cellularhistones inplasmahavebeendetected inpatients in
septic shock, and it has been shown that extracellular his-
tones released in response to experimental sepsis contrib-
ute to endothelial dysfunction, organ failure, and death
(10–12). Histones also play important roles in sterile sepsis
that occur after chemically induced acute liver injury,
hemorrhagic shock, or ischemia-reperfusion injury (8, 9).
Histones have been detected in blood from baboons chal-
lengedwith liveEscherichia coli (10).Neutralizing antibodies
to histones reduced mortality in mice infused with TNF or
LPS, as well as in mice with polymicrobial sepsis (10), sug-
gesting that extracellular histones are major mediators of
death in sepsis. In the settingof trauma, circulatinghistones
were detected in plasma immediately after nonthoracic
blunt trauma inhumans, accompanied by acute lung injury
(ALI) (12, 13). In rodents with C5a-induced ALI, extracel-
lular histones appeared in broncho-alveolar lavage ﬂuids
(BALF), as well as in BALF fromhumans with ALI. Histone
appearance was complement and polymorphonuclear
leukocyte (PMN)-dependent (14). Histone administration
into mouse airways caused intense inﬂammation, dam-
age of alveolar epithelial cells, release of cytokines/
chemokines, and severe disturbances in gas exchange in
lungs together with prominent thrombi in pulmonary
veins. Using a mAb with neutralizing activity for
Abbreviations: ALI, acute lung injury; BALF, bron-
choalveolar lavage ﬂuid; C5aR1, C5aR2, receptors for the
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C5aR and CD88; C5aR2, earlier known as C5L2; CLP, cecal
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extracellular histones, these defects were markedly atten-
uated (14). The current report suggests that extracellular
histones act as DAMPs and are linked to development of
cardiac dysfunction during sepsis. Use of neutralizing
mAbs to histones was found to be heart protective.
MATERIALS AND METHODS
Animals and anesthesia
All procedures conformed to theGuide ofCare andUse of Laboratory
Animals published by the U.S. National Institutes of Health. The
studywas approvedby theUniversity Committee onUse andCare
of Animals and performed according to appropriate guidelines.
Speciﬁc pathogen-free male Sprague-Dawley rats (300–350 g;
Harlan Laboratories, Indianapolis, IN, USA) andmale C57BL/6
mice (6–10 weeks, 20–30 g; The Jackson Laboratory, Bar Harbor,
ME, USA) were anesthetized using the combination of ketamine
(Hospira, Lake Forest, IL, USA) and xylazine (Lloyd Laboratories,
Shenandoah, IA,USA) intraperitoneally.NLRP32/2, caspase12/2,
TLR 22/2, andTLR42/2micewere purchased fromThe Jackson
Laboratory.C5aR12/2andC5aR22/2miceweregenerated inour
own laboratories, as described earlier (15, 16). The number of
mice used in each experiment is detailed in legends to ﬁgures.
Reagents
The following reagents were used: neutralizing histone antibody
(clone BWA3) (17) and mouse IgGk isotype matched antibody
(BioLegend, San Diego, CA, USA); puriﬁed histones from calf
thymus and chemicals used for preparation of solutions for CM
isolation were purchased from Sigma-Aldrich (St. Louis MO,
USA). Endotoxin contamination of the histone preparations
was,0.02 EU/mg (LAL assay; Lonza, Allendale, NJ, USA).
Experimental sepsis
Sepsis was induced by the cecal ligation and puncture (CLP)
procedure as described previously in both rats and mice (18, 19).
Sham animals underwent the same procedure, including mani-
pulationof thebowel in the absenceof cecal ligationandpuncture.
All animals (sham andCLP) receivedﬂuid resuscitation (1.5ml
lactated Ringers, given subcutaneously in the nuchal region).
The animals were euthanized at times indicated after CLP.
Isolation of CMs
The isolation of adult rat or mouse CMs was performed as pre-
viously described, using a Langendorff perfusion system (20, 21).
The hearts were retrograde perfused with enzyme solution,
according to manufacturer’s directions (Liberase; Hoffmann-La
Roche,Mannheim,Germany). Followingdigestion, the heart was
detached from the Langendorff apparatus, atria and vessels were
removed, and theventricleswerecut into smallpieces,whichwere
gently triturated with a plastic transfer pipette. After isolation of
the CMs, the Ca2+ concentration in the buffer ﬂuid was gradually
increased (to 1.8 mM), and the cells were cultured in M199
medium with 1% insulin-transferrin-selenium-X (Gibco; Life
Technologies, Carlsbad, CA, USA) and antibiotic-antimycotic
(Invitrogen, Carlsbad, CA, USA). In some cases, anti-histone
neutralizing antibody or an irrelevant isotype control antibodywas
administered intravenously (400mg/mouse)at the timeofCLP. In
somecases, neutrophils weredepletedby intraperitoneal injection
of 150 mg anti-Ly6G (clone 1A8, or isotype control antibody, both
from BioLegend, San Diego, CA, USA) 12 hours prior to CLP.
Histone ELISA
Histones in mouse plasma were measured by using a cell death
detection ELISA kit that detects all histones (Hoffmann-La
Roche, Indianapolis, IN, USA). A histone mixture (containing
H2, H2A, H2B, H3, and H4) was used to establish a standard
curve, as previously described (14).
Measurement of [Ca2+]i and reactive oxygen species
Intracellular Ca2+ in CMs was measured by ﬂow cytometry using
Fluo3AM,whereas intracellular cytosolic reaction oxygen species
(ROS) was measured using CellROXDeep Red (Invitrogen, Life
Technologies, Carlsbad, CA, USA) according to manufacturer’s
directions.Aminimumof10,000eventswasanalyzedonaBDLSR
II ﬂow cytometer (BD Biosciences, San Jose, CA, USA) with Diva
Software (San Jose, CA, USA). Data were analyzed with FlowJo
Software 7.6.4 (Ashland, CA, USA).
Calcium currents in rat CMs
CMcalciumcurrentsweremeasuredaspreviouslydescribed(22).
Transthoracic echocardiography in mice
Echocardiograms were performed as previously described (23).
All echocardiograms were performed by a registered echocardi-
ographer who was blinded to experiment details. Mice were
weighed and anesthetized with inhaled isoﬂurane. Imaging was
performed according to the recommendations of the American
Society of Echocardiography using Vevo 770 Microimaging sys-
tem (Visualsonics Inc) equippedwith anRMV707B(15–45MHz)
transducer. Left ventricular area and left ventricular length
were measured from the parasternal long axis view and used to
calculate the left ventricular end systolic and diastolic volumes
as follows:
V ¼ 4/3p3
length
2
3 area=½pðlength=2Þ: (1)
The volumes at end systole (VolS) and end diastole (VolD) were
measured andused to calculate stroke volume (SV=VolD–VolS)
and ejection fraction (EF% = endocardial SV/endocardial VolD3
100). Cardiacoutput (CO=SV3heart rate)was calculated from
stroke volume and heart rate. Mitral valve E and A wave inﬂow
velocities were sampled at the tips of the leaﬂets of the mitral
valve from the apical 4-chamber view. Doppler tissue imaging
was performed with acquisition of peak E9 velocity from the
lateral (E9la) and septal annulus (E9sa)of themitral valve imaged
fromtheapical4-chamber view. Isovolumic relaxation time, from
the closure of the aortic valve to the opening of the mitral valve,
wasmeasured fromtheapical 5-chamber viewusingDopplerﬂow
imaging. Imaging was performed at 8 hours after CLP.
(continued from previous page)
FCCP, carbonyl cyanide 4-(triﬂuoromethoxy) phenylhydrazone;
LV, left ventricle; NET, neutrophil extracellular trap; NLRP3,
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TLR, toll-like receptor; TMRE, tetramethylrhodamine,
ethyl ester; WT, wild-type
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Mitochondrial mass and membrane potential cYm
The cell-permeable carbocyanine-based MitoTracker Deep Red
(Invitrogen)wasused tomeasuremitochondrialmass inCMsand
other features. This dye is cell permeable, accumulating selec-
tively in mitochondria. Flow cytometry was performed as de-
scribed above. The mitochondrial membrane potential was
obtained by using the dye, tetramethylrhodamine, ethyl ester
(TMRE; Mitochondrial Membrane Potential Assay Kit; Abcam,
Cambridge, MA, USA). TMRE is cell-permeable, positively
charged, and accumulates in active mitochondria because of
the relative negative charge of mitochondria. Carbonyl cyanide
4-(triﬂuoromethoxy)phenylhydrazone (FCCP) is an ionophore
uncoupler of oxidative phosphorylation, which eliminates mito-
chondrial membrane potential and TMRE staining and is used as
a control.
ATP detection in CMs
Total levels of cellular ATP were obtained by using the Lumi-
nescentATPDetectionAssayKit (Abcam,Cambridge,MA,USA).
In brief, the kit is based on ﬁreﬂy (Photinus pyralis) luciferase and
determines the total level of cellular ATP. The cells were plated
with 12,000 cells per well in a 96-well plate. The kit is based on
the production of light caused by reaction of ATP with added
luciferase and D-luciferin, using Inﬁnite F200 luminescence
instrument (Tecan, Salsburg, Austria).
FITC-labeled histones
FITC (37.5mg; Sigma-Aldrich)was conjugated to 1mgmixed calf
thymus histones. For in vivo experiments 45 mg/kg body weight
histones were injected intravenously, and FITC in heart homo-
genates was analyzed by ﬂuorescence plate reader (excitation,
485 nm; emission, 535 nm).
Confocal imaging
For confocal imaging, CMs were cultured on sterile glass coverslips
coatedwithnaturalmouseLaminin(LifeTechnologies).Cellswere
incubated with FITC-conjugated histones for 30 minutes and then
washed and ﬁxed. Confocal imaging was performed with a Zeiss
LSM 510 Confocal microscope (Zeiss USA, Pleasanton, CA, USA).
Statistical analysis
All values were expressed asmeans6 SEM. Datasets were analyzed
by 1-way ANOVA followed by Dunnett’s or Tukey’s multiple
comparison test or by Student t test. P , 0.05 was considered
statistically signiﬁcant. GraphPad Prism 6.0 software was used for
statistical analysis (GraphPad Software, Incorporated, San Diego,
CA, USA). In the case of echocardiogram/Doppler data, each
mouse was tested before and 8 hours after CLP, allowing paired
t testing analysis for each mouse.
RESULTS
Requirements for appearance of plasma histones
after CLP
These studies were designed to measure appearance in
plasma of extracellular histones after CLP, the extent to
which both C5a receptors were required for histone pres-
ence, the requirement for PMNs, evidence for the role
of the NLRP3 inﬂammasome, and evidence that in-
travenously infusion of FITC-labeled histones resulted in
buildup inCMs.C57BL/6 young adult (20–30 g)malemice
underwentCLPasdescribedearlier(19).Thedata inFig.1A
indicate that plasma histones were detected (by ELISA
technology) 6 hours after CLP in wild-type (WT) mice and
persisted for 24 hours, followed by reduction. Fig. 1B indi-
cates that the absence of either C5a receptor (C5aR1 and
C5aR2) resulted in anearly 80% fall in plasmahistone levels
after CLP, whereas PMNdepletion caused a 77% reduction
in plasma levels of histones 12 h after CLP (Fig. 1C), in-
dicating a linkage between histone appearance after CLP
and PMN availability and C5a receptors. Fig. 1D shows a re-
quirement for theNLRP3protein inﬂammasome inhistone
buildup in plasma after CLP, because absence of NLRP3
protein or caspase 1 resulted in 69% and 84% reductions,
respectively, in plasma histone levels 16 h after CLP. The
data in Fig. 1E indicate that FITC-labeled histones given
intravenously to WT (non-CLP) mice localized in the heart
30minutes later. In Fig. 1F, when CMs were exposed in vitro
to FITChistones, histone localization could be seen bothon
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Figure 1. Requirements for histone appearance in
plasma after CLP and binding of histones to CMs.
A) Time course (hours) for extracellular histone
appearance in plasma from C57BL/6 (WT) mice
after CLP. B) Requirements for both C5a recep-
tors (C5aR1, C5aR2) for histone appearance in
plasma 12 hours after CLP. C) PMN dependence
for histone appearance in plasma 12 h after CLP,
using the mAb that depletes blood PMN via
reactivity with the Ly-6G epitope on PMNs. D)
Histone appearance in plasma after CLP is
dependent on the NLRP3 inﬂammasome. E)
Thirty min after intravenous infusion of FITC-
histones (45 mg/kg body weight) into WT mice,
heart homogenates contained histones. F) Con-
focal microscopy of rat CMs exposed in vitro to
ﬂuorescein-labeled histones (50 mg/ml) for
30 minutes at 37°C, showing both surface binding
of histones (upper), as well as evidence of histone
internalization into CM cytosol (lower). Nuclei are
deﬁned by DAPI stain (blue). For all frames, n $ 6
for each bar. *Differences were signiﬁcant, P, 0.05
(A) vs. sham and (B) vs. WT, or as indicated.
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the plasma membrane (upper CM) and in the cytosol
(lower CM) of cells.
Increased ROS and [Ca2+]i in CMs exposed
to histones
Because there is published evidence that CLP perturbs the
redox status andmay feature buildup of [Ca2+]i in CMs, a se-
ries of in vitro and in vivo studies involving changes in CMs
exposed to histones was carried out.We assessed the ability of
histones tocauseelevations inROSand[Ca2+]i inmouseCMs,
usingﬂowcytometric techniques.CMswere loadedwithﬂuro-
3 AM or with Cell ROXDeep Red. In Fig. 2A, a histone mix-
ture in a dose-dependent manner (0.5–100 mg/ml) caused
increasedcytosolicROS inCMsand related to thedurationof
exposure of CMs (10–60 min; Fig. 2B). In Fig. 2C, when his-
tones were infused intravenously (65 mg/kg body weight)
intoWTmice, CMs isolated 30minutes later showed a signif-
icant increase in cytosolic ROS as detected by ﬂow cytometry
compared with sham CMs (control). In Fig. 2D–G, increases
in CM [Ca2+]i after histone exposure in vitro were time de-
pendent (Fig. 2D) anddosedependent (Fig. 2E). Intravenous
infusion of the histone mixture increased [Ca2+]i in mouse
CMs (Fig. 2F), as was the case with cytosolic ROS. After
in vitroexposuretohistoneconcentrationsintherangefound
in plasma after CLP (Fig. 1A), [Ca2+]i increases were mag-
niﬁed in CMs fromCLPmice compared with non-CLPCMs
(Fig. 2G). When WT and TLR-null (TLR22/2 or TLR42/2)
mice were infused intravenously with histones, 30 minutes
later [Ca2+]i was increased in CMs from WT mice (Fig. 2H,
black bar vs. white bar), but not in CMs from TLR22/2 or
TLR42/2mice (gray bars), consistent with the literature sug-
gesting that histones function as ligands for theseTLRs (7–9).
Functional defects in CMs and hearts after exposure
to histones
We assessed effects of histones on single isolated mouse
CMs preloaded with Fluo3 AM and electrically paced as
described elsewhere (22). Details are provided in the
Materials andMethods. In addition,mouse hearts perfused
with histones were assessed for changes in left ventricle
(LV) pressures and ECG tracings. Details of Langendorff
perfusion techniques are described elsewhere (20, 21). As
shown in Fig. 3A, there were progressive increases in base-
line [Ca2+]i after addition of histones to electrically paced
CMs, indicating defective [Ca2+]i clearance during diastole,
as well as a widening of the Ca2+ transients and a pro-
gressively risingbaseline for [Ca2+]i. Therewasaprogressive
reduction in the amplitudes of the calcium transients. In
Fig. 4, the tracings were magniﬁed to emphasize widening
of the calcium transients after CM exposure to histones.
Less than 1 minute after addition of histones, Ca2+ tran-
sients began to widen (Fig. 4, lower), indicating defective
cytosolic clearance of Ca2+ in CMs. In Fig. 3B, Langendorff
mouse hearts (WT) perfused with the histone mixture
showed progressive reductions and narrowing of LV pres-
sure tracings, indicating defects in contractility responses.
In Fig. 3C–E, ECG tracings demonstrated normal sinus
rhythm (Fig. 3C) and histone-induced arrhythmias: sinus
bradycardia (Fig. 3D) and ventricular bigeminy (Fig. 3E).
Bigeminy was conﬁrmed by LV pressure recordings (Fig.
3F). Accordingly, histones in vitro induced a variety of
defects that would be expected to have important negative
functional consequences on heart performance.
Histone-induced defects in mitochondria
Functional mitochondria are essential for cardiac func-
tions. Fig. 5 shows histone effects on mitochondria in rat
CMs, in some cases using compounds that are cell per-
meable and mitochondrial seeking. Rat CMs were used
because of their abundance and stability as contrasted to
mouse CMs. In Fig. 5A, high concentrations of histones
($500mg/ml) causedannexinVbinding toCMs, a feature
predictive of apoptosis. In Fig. 5B, we used amitochondrial
membrane potential indicator dye (TMRE), which is cell
permeable, its charge (positive) resulting in a buildup in
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Figure 2. Appearance of increased
levels of ROS and [Ca2+]i mouse
in CMs exposed to a histone mix-
ture. All data were obtained by ﬂow
cytometry. A) Cytosolic ROS re-
sponses of CMs exposed 30minutes
at 37°C to histones as function of
histone concentrations. B) Cytosolic
buildup of ROS in CMs exposed to
histones (50 mg/ml) at 37°C for the
times indicated. C) Increased ROS
in CMs from mice infused intrave-
nously with histones 30 minutes
earlier (65 mg/kg body weight).
D) [Ca2+]i increases in CMs exposed
to histones (50 mg/ml) for the in-
dicated periods of time at 37°C. E)
[Ca2+]i responses of CMs as a fun-
ction of concentration of histones. F)
[Ca2+]i increases in heart after intrave-
nousinfusionofhistones(65mg/kg
body weight) into mice 30 minutes earlier. G) [Ca2+]i increases in CMs obtained from sham or CLP mice and exposed in vitro for
30 minutes at 37°C to histones (5 mg/ml).H) [Ca2+]i in CMs obtained from shammice or from TLR4
2/2, TLR22/2, or WTmice
infused intravenously 30minutes earlier with histones or PBS (shamWTmice). For each bar, n$ 6. *Differences were signiﬁcant,
P, 0.05 vs. control or as indicated.
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activemitochondria (which bear a negative charge). FCCP
is an ionophore that uncouples oxidative phosphorylation,
eliminating the mitochondrial membrane potential and
TMRE staining, which were used as controls. There was a
progressive loss of mitochondrial membrane potential
caused by exposure of CMs to increasing concentrations
of histones. CMs exposed to histones also had dramatic
reductions in ATP as a function of histone concentrations
(Fig. 5C).Levels ofATPwereobtainedusing a luminescent
ATP detection assay kit. Finally, histones caused dose-
dependent increases in mitochondrial mass as assessed by
ﬂow cytometry (Fig. 5D), likely because of the buildup
of ﬂuids within mitochondria (resulting in swelling). In-
terestingly, several of these responses occurred within
the dose range of histones appearing in plasma after CLP
(Fig. 1A).
Direct evidence for the role of histones in cardiac
dysfunctions after sepsis
To determine whether a linkage exists between histones
and the in vivo functional defects in cardiovascular per-
formance developing after CLP (Fig. 6), ECHO/Doppler
parameters were measured before (white bars) and 8 h
after CLP (black and gray bars). In CLP mice, 65 mg
isotype-matched IgG isolated from normal serum from
mice (nsIgG) (graybars) orwith 65mgneutralizingmAb to
histones (black bars) were infused intravenously just be-
fore CLP. Mice subjected to CLP demonstrated signiﬁcant
abnormalities in systolic (Fig. 6A–D) and diastolic (Fig.
6E–H) parameters that were partially or completely re-
versed by administration of neutralizing mAb to histones.
For instance, CLP mice given nsIgG (gray bars) demon-
strated modest but signiﬁcantly decreased heart rates,
whereas mice treated with a neutralizing mAb to histones
had heart rates similar to sham-operated controls (Fig. 6A,
whitevs. black andgray bars). CLPalso causeda substantial
decrease in LV stroke volume (black bar) and cardiac
output (Fig. 6B, C) (white vs. gray bars). mAb treatment
partially reversed the decrement in stroke volume (Fig.
6B), whereas the cardiac output in CLP mice given the
histone-neutralizing mAb was comparable to sham-oper-
ated controls (Fig. 6B). The CLP-mediated decrease in
cardiac output did not appear to be caused by direct
myocardial depression, because the LV ejection fraction
was increased after CLP and further increased by histone
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Langendorff mouse hearts per-
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(B–F). LV pressures were measured
(B, F) and also monitored by ECG
tracings (C–E). A) Isolated cardio-
myocytes were loaded with an in-
tracellular calcium indicator (Fluo3
AM) and calcium change was mea-
sured during electrical pacing (0.5
Hz). Histones caused calcium over-
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showing falling andnarrowingof pres-
sure tracings after perfusion with
histones (arrow). C–E) ECG tracings
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(normal sinus rhythm) (C) and after histone exposure, which caused sinus bradycardia (D) and ventricular bigeminy (E), which
was conﬁrmed by LV pressure tracings (F). Tracings are representative of 11 independent experiments.
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and after (B) addition of the histone mixture (5 mg/ml). In the
lower panel, there was expanding width of intracellular calcium
tracings, indicating defective [Ca2+]i clearance during diastole.
Tracings are representative of patterns in which n $ 4 each.
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mAb infusion (Fig. 6D). Therefore, reduced cardiac out-
put 8 h after CLP was primarily caused by changes in ven-
tricular volumes and heart rates rather than direct
myocardial suppression.
The diastolic abnormalities caused by CLP were also
prevented by histone mAb infusion (Fig. 6E–H). Iso-
volumic relaxation was signiﬁcantly prolonged 8 hours af-
ter CLP but was restored to normal by histone mAb
treatment (Fig. 6E). Doppler tissue imaging revealed de-
creased passive ﬁlling (E9) velocities at the septal (Fig. 6F)
and lateral (Fig. 6G) mitral valve annulus 8 h after CLP.
Infusion of mAb prevented the abnormalities in mitral
annular velocities after CLP. The decreased end diastolic
volume noted after CLP was not signiﬁcantly improved by
histonemAb infusion (Fig. 6H). This suggests that changes
in ventricular volumes after CLP may be caused by third
space ﬂuid losses affecting loading conditions. In contrast,
the cardiac diastolic dysfunction observed after CLP may
be caused by elevations in [Ca2+]i in CMs in response to
histone exposure. These abnormalities were prevented by
infusion of mAb to histones (black vs. white bars), whereas
nonspeciﬁc IgG (gray bars) was not protective.
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DISCUSSION
The linkage between histone appearance and cardiac
dysfunction during sepsis is described in this report. It is
known that infusion of large amounts of histones intomice
results in multiorgan failure and death (10). In heart fail-
ure (24) or during myocardial remodeling after ischemia-
reperfusion injury (25), histonesmay play a role in cardiac
dysfunction, although the evidence is limited. After in-
travenous injection of histones into mice, pulmonary hy-
pertension and right-sided heart failure developed and
were followedby ventricular arrest, associatedwithhistone-
induced thromboembolism in the lungs. Platelet-depleted
mice were transiently protected from histone-mediated
death within the ﬁrst 30 min, but the protective effects of
platelet depletion disappeared soon thereafter (26), sug-
gesting that additional cellular andmolecularmechanisms
are involved in histone-induced cardiac dysfunction dur-
ing sepsis.
In the data presented in this report, we conﬁrmed the
appearance of histones in plasma after CLP, similar to an
earlier report (9), and provided evidence that use of an
mAb that has neutralizing activities to histones (H2A, H4)
(17) reduces or abolishes defects in systolic and diastolic
function in the heart appearing after CLP, based on
ECHO/Doppler parameters. These ﬁndings are consis-
tent with observations that neutralizing antibodies against
histones reduced mortality in mice infused with TNF or
LPS, as well as in mice with sepsis following CLP (10).
In an ex vivo model, Langendorff-perfused mouse
hearts showed progressive reductions in LV pressure trac-
ings after perfusion with histones, resulting in defects in
contractility responses (Fig. 3). Studies in septic humans
using echocardiography demonstrated slower left ventric-
ular ﬁlling and aberrant left ventricular relaxation time
(27, 28), suggesting that impaired compliance may con-
tribute to myocardial depression during sepsis. The cur-
rent studies establish a direct relationship between
histones and cardiac dysfunction in sepsis following CLP.
The requirement of PMNs for histone appearance in
plasma after CLP in our current study is similar to our
recent report in ALI in which PMN depletion reduced the
histone appearance in BALF (14). As well, histones were
found in BALFs from humans with ALI. Our recent report
also describes the requirement for the NLRP3 inﬂamma-
some in developing ALI and demonstrates that in vitro ac-
tivation of PMNs by C5a can cause the appearance of
histones in supernatant ﬂuids, presumably released from
neutrophil extracellular traps (NETs) (29). Histones in
plasma obtained from mice 8 hours after CLP were sig-
niﬁcantly reduced in the absence of C5aR1, C5aR2, or
NLRP3, linking the complement and innate immune sys-
tems. Observations describing improved survival in CLP
mice with genetic deﬁciency of either C5aR1 or C5aR2
(30) denote a linkage between C5a, its receptors, and his-
tone release in sepsis. Furthermore, histones promoted
thrombus formation (31) and were found to enhance
plasma thrombin generation (32). Fig. 7 describes the
pathways in sepsis leading to histones appearance and ul-
timate cardiac dysfunction. Accordingly, thrombin is also
known togenerateC5a fromC5(in the absenceofC3), the
product being biologically active and structurally identical
to C5a generated by the C5 convertase (33). Thrombin
potentially can act as an ampliﬁer of complement effector
generation. Another activator of C5 found in trauma
patients is factor VII-activating protease, which is activated
byhistones(34). In summary, thedata in this report indicate
that theappearanceof extracellularhistones inplasmaafter
CLP engages 3 arms of the innate immune system: the
complement system (C5a and its receptors), PMNs, and the
NLRP3 inﬂammasome. Although the precise links that or-
chestrate these connections are inadequately understood, it
seems likely that the early initiating events in sepsis are
complement activation with C5a generation and engage-
ment of both C5aR1 and C5aR2 (Fig. 7).
The mechanism of histone-induced cell injury is un-
clear. Calcium inﬂux caused by plasma membrane dis-
ruption (12) may be a mechanism of histone-induced
toxicity. Inour studies, histones cause impressive elevations
in [Ca2+]i in CMs, as measured by ﬂow cytometry. Elec-
trophysiological measurements in paced cardiomyocytes
exposed to histones conﬁrmed an accumulation of cyto-
solic calcium (Fig. 3). In CMs, this buildup was inde-
pendent of translocation of extracellular Ca2+ into the
CMs (data not shown). Defective Ca2+ handling in the cy-
tosol caused by reduced Ca2+ sequestration into the sar-
coplasmic reticulumhas been found in the failinghuman
myocardium (35). These ﬁndings are contrary to studies
showing in endothelial cells that calcium inﬂux from ex-
tracellular sites is associated with histone-induced damage
(12) and that cell dysfunction caused by histones may
be related to the interaction of histones with membrane
Sepsis, Histones and Cardiac Dysfunction
Polymicrobial Sepsis
Complement Activation
C5aPMNs
NETs
histones
Plasma Histones
Cardiomyocyte Dysfunction
Septic Shock
Multiorgan Failure
Lethality
C5aR1, C5aR2
TLR2, TLR4
Figure 7. The cardiomyopathy of sepsis requires C5a, its
receptors, and PMNs, whereas cardiac dysfunction is linked to
appearance of histones. Proposed sequence of events after
CLP (polymicrobial sepsis), leading to complement activation,
with dependence on C5a receptors and PMNs for histone
appearance in plasma. Histones, which interact with TLR2
and TLR4 on a variety of cell types, including CMs, cause cell
damage, organ dysfunction, and lethality.
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phospholipid bilayers (36), followed by an increase of
membrane permeability (37). In our studies, isolated CMs
incubated with histones in vitro showed accumulation of
histones on the cellmembrane and in the cytosol (Fig. 1F).
There are suggestions that in vitro and in vivo responses to
DAMPs require TLR2 and TLR4 (9, 10, 38). When wild-
type and TLR-null (TLR22/2 or TLR42/2) mice were
infused intravenous withhistones, 30minutes later [Ca2+]i
was increased in CMs from WT, but not in CMs from
TLR22/2 or TLR42/2, mice (Fig. 2H). Such data are con-
sistent with reports suggesting that histones may func-
tion as ligands for TLR2 and TLR4 (8, 9). Interestingly,
TLR2 and 4 were found to be involved in plasma pro-
thrombin activation (32), which resulted in ampliﬁed
C5a generation.
CMs isolated after infusion of extracellular histones
showed, as did cultured CMs in the presence of histones,
increases in cytosolic and nuclear/mitochondrial ROS
(Fig. 2). ROS may play an important role in the patho-
genesis of myocardial dysfunction in cardiovascular dis-
eases, such as ventricular hypertrophy, heart failure, atrial
ﬁbrillation, andmyocardial ischemia (39). Redox sensitive
signaling pathways are critically involved in multiple CM
functions such as contractile performance, rhythmicity,
hypertrophy, and responses to stress (40). ROSmodulates
Ca2+ handling proteins by oxidation of thiol (-SH) groups,
leading to Ca2+ increases of the cytosol (41), as well as
blocking ATP-binding sites on SERCA2, resulting in cyto-
solic Ca2+ overload (42). Collectively, our data suggest that
histones induceelevations inCMROSand[Ca2+]i thatmay
be linked to defective CM function, as also suggested in
other reports (39, 40, 43, 44).
The combination of histones, together with oxidants
andproteases frombothPMNsandmacrophages, seems to
represent the distal pathways leading to organ injury, as
summarized in Fig. 7. In the present studies, we showed
that treatment of isolated CMs with histones resulted in
decreased mitochondrial membrane potential and de-
creased ATP levels, which have been associated with car-
diac dysfunction (45–47). Interestingly, these intracellular
changes occurred within the dose ranges of histones
appearing in plasma after CLP. In our studies, we found
increasedannexinVbinding in cardiomyocytes exposed to
high concentrations of histones. Our data indicate that in
polymicrobial sepsis, complement activation lends to C5a
generation and its engagement with C5aR1 and C5aR2,
collectively resulting in NET formation and release of his-
tones. Histones presumably function as ligands for TLR2
and 4, associated with cardiac dysfunction, septic shock,
and lethality. Increased intracellular calcium and cyto-
chrome c released from damaged mitochondria (48, 49)
may amplify apoptotic signals. It is important to note that
induction of apoptosis in CMs required doses of histones
that were beyond plasma levels of histones in CLP mice
(Fig. 1). Such observations would be consistent with recent
reports in which autopsy frompatients with severe sepsis or
septic shock failed to reveal evidence of myocardial apo-
ptosis (50), as well as with reports that cardiacMRI analysis
performed 6 weeks after early imaging in sepsis showed
complete recovery of cardiac contractility (51). Finally, the
importance of C5a and its receptors in histone production
in sepsis is underscored by a recent review that emphasizes
how the complement and coagulation systems collaborate
to generate C5a in a variety of situations in which in-
ﬂammatory injury occurs (52).
Taken together, our results suggest that the presence of
extracellular histones occurring after CLP can be linked to
appearance of defects in cardiac function during sepsis.
Neutralizinghistone antibodiesor drugs that blockhistone
interactions with CMs may be potential therapeutic strat-
egies to prevent or ameliorate septic cardiomyopathy. It is
also possible that histone neutralization combined with
a neutralizing mAb to C5a might represent an effective
strategy for treatment of patients with sepsis.
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